タイトル |
-
en
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
|
作成者 |
|
アクセス権 |
open access |
主題 |
-
Other
en
Nanoparticle-targeted proapoptotic peptide
-
Other
en
Adipotide
-
Other
en
Diet-induced obesity
-
Other
en
Metabolic syndrome
-
Other
en
Ectopic fat
-
Other
en
Antiangiogenesis
-
NDC
499
|
内容注記 |
-
Abstract
en
Antiangiogenesis has been the focus of a new strategy for the treatment of obesity. However, little is known regarding the issue of whether targeting angiogenesis by nanoparticle-targeted therapeutic is advantageous or not in debugging the co-morbidity associated with diet-induced obesity (DIO) and the metabolic syndrome. We report herein on the positive effect of prohibitin (an adipose vascular marker)-targeted nanoparticle (PTNP) encapsulated in a proapoptotic peptide [(D)(KLAKLAK)(2), KLA] on DIO and dysfunctional adipose tissue, a major mediator of the metabolic syndrome, as evidenced by ectopic fat deposition. The systemic injection of DIO mice with a low dose of KLA-PTNP, rather than a bioconjugate composed of the same targeting peptide and KLA (Adipotide) resulted in a reduction in body weight, as evidenced by a significant decrease in serum leptin levels, in parallel with an antiobesity effect on dysfunctional adipose cells, including adipocytes and macrophages. In addition, the KLA-PTNP treatment resulted in a reduction in ectopic fat deposits in liver and muscle with the lipolytic action of elevated serum adiponectin, with no detectable hepatoxicity. Notably, drug delivery via PTNP that had accumulated in obese fat via the enhanced permeability and retention effect was enhanced by multivalent active targeting and cytoplasmic delivery into adipose endothelial cells via escaping from endosomes/lysosomes. Thus, vascular-targeted nanotherapy has the potential to contribute to the control of adipose function and ectopic fat deposition associated with obesity and the metabolic syndrome. (C) 2013 Elsevier B. V. All rights reserved.
|
出版者 |
en
Elsevier science bv
|
日付 |
|
言語 |
|
資源タイプ |
journal article |
出版タイプ |
AM |
資源識別子 |
HDL
http://hdl.handle.net/2115/54123
|
関連 |
-
isVersionOf
DOI
https://doi.org/10.1016/j.jconrel.2013.07.013
-
PMID
23871959
|
収録誌情報 |
-
-
en
Journal of controlled release
-
巻171
号2
開始ページ104
終了ページ112
|
ファイル |
|
コンテンツ更新日時 |
2023-07-26 |